Can Ozempic end addiction? | Dhruv Khullar | Your Body on Tech

GLP-1 medications, originally developed for diabetes and weight management, are emerging as potential treatments for various addictions by modulating the brain's mesolimbic reward pathway. By blunting dopamine spikes, these drugs may help individuals achieve moderation in behaviors ranging from alcohol consumption to compulsive shopping. Dr. Dhruv Khullar, a physician and researcher, highlights that while these "moderation molecules" offer a promising tool for addiction recovery, they are not a panacea. Significant concerns regarding long-term safety, muscle loss, and high costs persist, necessitating a cautious approach. Furthermore, relying on pharmacological interventions risks ignoring the underlying societal drivers of addiction, such as poverty and trauma. Ultimately, these medications represent a shift in understanding addiction as a neurobiological condition rather than a moral failing, though they must be integrated into comprehensive, patient-centered care rather than treated as a quick fix for complex human struggles.